HCW Biologics (HCWB) Equity Ratio (2020 - 2025)
Historic Equity Ratio for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to 0.08.
- HCW Biologics' Equity Ratio rose 7794.1% to 0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08, marking a year-over-year increase of 7794.1%. This contributed to the annual value of 0.22 for FY2024, which is 14742.63% down from last year.
- HCW Biologics' Equity Ratio amounted to 0.08 in Q3 2025, which was up 7794.1% from 0.0 recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Equity Ratio ranged from a high of 0.97 in Q2 2022 and a low of 1.78 during Q2 2021
- Its 5-year average for Equity Ratio is 0.3, with a median of 0.57 in 2023.
- Per our database at Business Quant, HCW Biologics' Equity Ratio skyrocketed by 18810.7% in 2021 and then plummeted by 21339.4% in 2025.
- HCW Biologics' Equity Ratio (Quarter) stood at 0.96 in 2021, then decreased by 16.41% to 0.8 in 2022, then tumbled by 40.96% to 0.47 in 2023, then tumbled by 147.43% to 0.22 in 2024, then skyrocketed by 63.01% to 0.08 in 2025.
- Its Equity Ratio was 0.08 in Q3 2025, compared to 0.0 in Q2 2025 and 0.33 in Q1 2025.